Clinical Trial Update: REsearching Coronary REduction by Appropriately Targeting Euglycemia (RECREATE Pilot Study) [Phase 3]

View source ↗

Summary

The RECREATE Pilot Study, a Phase 3 trial evaluating targeting euglycemia to reduce coronary events in hyperglycemic patients, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases
• Hyperglycemia
• Myocardial Infarction

Snippet

Sponsor: Population Health Research Institute | Conditions: Hyperglycemia, Cardiovascular Diseases | Phase 3 | Status: COMPLETED